Cargando…
CD44 Glycosylation as a Therapeutic Target in Oncology
The interaction of non-kinase transmembrane glycoprotein CD44 with ligands including hyaluronic acid (HA) is closely related to the occurrence and development of tumors. Changes in CD44 glycosylation can regulate its binding to HA, Siglec-15, fibronectin, TM4SF5, PRG4, FGF2, collagen and podoplanin...
Autores principales: | Liao, Chengcheng, Wang, Qian, An, Jiaxing, Chen, Jie, Li, Xiaolan, Long, Qian, Xiao, Linlin, Guan, Xiaoyan, Liu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351704/ https://www.ncbi.nlm.nih.gov/pubmed/35936713 http://dx.doi.org/10.3389/fonc.2022.883831 |
Ejemplares similares
-
SPINKs in Tumors: Potential Therapeutic Targets
por: Liao, Chengcheng, et al.
Publicado: (2022) -
B7 family protein glycosylation: Promising novel targets in tumor treatment
por: Xiao, Linlin, et al.
Publicado: (2022) -
Changes in Protein Glycosylation in Head and Neck Squamous Cell Carcinoma
por: Liao, Chengcheng, et al.
Publicado: (2021) -
Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996) -
The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
por: Guo, Ting, et al.
Publicado: (2022)